The good news is that fewer people are dying from heart attacks. The bad news is that hundreds of thousands of people are living with badly damaged hearts and heart failure.
Heart failure cuts short thousands of lives every year, but now scientists have the first real hope that these lives could be saved. The British Heart Foundation have recently launched a campaign to fund groundbreaking research.
NICE gives the green light for new heart attack drug
Ticagrelor, a new drug that could prevent one in five heart attack deaths, has been approved for use in patients by the National Institute for Health and Clinical Excellence (NICE).
Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, has led UK investigations into the novel drug for the past 15 years. He said: "The approval by NICE is excellent news as this now provides a path for the introduction of ticagrelor across England and Wales.
